论文部分内容阅读
近十年来,随着淋巴细胞亚群识别技术的迅速发展,尤其单克隆抗体应用以来,淋巴细胞增殖性疾病(LPD)的分类越来越引起人们的关注。LPD 过去基本是按照组织学特点来分类,这种分类方法不能完全反映其临床、细胞学和生物学特征。按照LPD 细胞表面免疫学标记分类,能较全面地反映出疾病的本质。本文根据这方面的新进展,重点讨论T 细胞LPD 的免疫学分类问题。
In recent ten years, with the rapid development of lymphocyte subsets identification technology, especially the application of monoclonal antibodies, the classification of lymphoproliferative diseases (LPD) has drawn more and more attention. In the past, LPD was classified according to histological features. This classification method can not fully reflect its clinical, cytological and biological characteristics. In accordance with the classification of LPD cell surface immunological markers, can more fully reflect the nature of the disease. Based on the recent advances in this area, this article focuses on the immunological classification of T-cell LPD.